Company: HSDTW
Filing Date: 2025-03-26
Form Type: 424B5
Source: 0001104659-25-028242
Chunk: 14

Company: Solana Co
Filing Date: 2025-03-26
Form: 424B5
Chunk 14
---
 furnished pursuant to Item 9.01 of Form 8-K.

You may request a copy of these filings, at no cost, by writing or telephoning us at the following address or telephone number:

<div align='center'>Helius Medical Technologies, Inc. 
 642 Newtown Yardley Road, Suite 100 
 Attn: Jeffrey Mathiesen 
 Phone: (215) 944-6100</div>

We will not, however, send exhibits to these documents unless the exhibits are specifically incorporated by reference in those documents or deemed to be incorporated by reference in this prospectus. In addition, you may obtain a copy of these filings from the SEC as described above in the section entitled “Where You Can Find More Information.”

<div align='center'>S-10</div>

TABLE OF CONTENTS

### PROSPECTUS
<div align='center'>**$100,000,000**</div>

#### Common Stock

#### Preferred Stock

#### Debt Securities

#### Warrants
**From time to time, we may offer and sell an aggregate amount of up to $100,000,000 of any combination of the securities described in this prospectus, either individually or in combination, in one or more offerings. We may also offer securities as may be issuable upon conversion, redemption, repurchase, exchange or exercise of any securities registered hereunder, including any applicable antidilution provisions.

This prospectus describes some of the general terms that may apply to an offering of our securities that we may offer. Each time we offer securities, we will provide specific terms of the securities in one or more supplements to this prospectus. We may also authorize one or more free writing prospectuses to be provided to you in connection with these offerings. The prospectus supplement and any related free writing prospectus may also add, update or change information contained in this prospectus. You should carefully read this prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as any documents incorporated by reference, before you invest in any of the securities being offered.

This prospectus may not be used to consummate a sale of any securities unless accompanied by a prospectus supplement .

As of March 31, 2023, the aggregate market value of our outstanding common stock held by non-affiliates, or public float, was approximately $7,335,478.28 million based on 28,213,378 shares of outstanding common stock, at a price of $0.26 per share, which was